Multimodal Analgesic Management of Naborphine Combined With Opioid Free Anesthesia in OSA Patients Undergoing Bariatric Surgery

Bariatric Surgery Clinical Trial

Official title:

Multimodal Analgesic Management of Naborphine Combined With Opioid Free Under General Anesthesia in OSA Patients Undergoing Weight Loss Surgery Under the Concept of ERAS: a Prospective, Randomized, Parallel Controlled Study

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05386979
• Other study ID #: YXLL-KY-2022(035)
• Status: Not yet recruiting
• Phase: N/A
• Start date: May 15, 2022
• Est. completion date: October 31, 2023

Study information

• Verified date: May 2022
• Source: Qianfoshan Hospital
• Contact: Yongtao Sun, doctor
• Phone: 18660795201
• Email: sunyongtao1979[@]163.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Comparative study to explore the effect of opioid free anesthesia technology in perioperative analgesia management, clarify the effect of naborphine instead of opioids on perioperative analgesia management in morbid obesity patients with moderate and severe OSA, reduce related adverse events, and explore the latest clinical anesthetic drugs.

Description:

1. The concept of enhanced recovery after surgery (ERAS) has been applied in the perioperative period of many operations. Reducing the dosage of opioids is an important part of the concept of ERAS. 2. Opioid free anesthesia technology has been recognized in reducing nausea and vomiting, but whether it can meet the perioperative analgesic needs of patients undergoing bariatric surgery and obtain more clinical benefits still has no research supportment. 3. This study is expected to clarify the clinical effect of opioid free anesthesia technology in perioperative analgesia management of morbid obesity patients with moderate and severe OSA, reduce adverse events, and explore the latest clinical anesthesia scheme.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 48
• Est. completion date: October 31, 2023
• Est. primary completion date: January 31, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

1. ASA grade I ~ III;

2. Age from 18 - 65 years old;

3. BMI = 35kg / m2 in patients with OSA to undergo bariatric surgery; (4 provide written informed consent for participation.

Exclusion Criteria:

1. Age < 18 years or age >65 years old;

2. Pregnancy test was positive;

3. Patients with a history of drug abuse or dependence on opioids;

4. Patients with chronic pain or severe heart, lung, liver or nervous system diseases

Related Conditions & MeSH terms

• Bariatric Surgery

Intervention

Procedure:
• Opioid free anesthesia technology
We have adopted a variety of methods to replace the use of opioids in the process of balanced anesthesia.

Locations

Country	Name	City	State
China	Yongtao Sun	Jinan	Shandong

Sponsors (1)

Lead Sponsor	Collaborator
Qianfoshan Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	postoperative NRS score	A subjective psychometric response scale used to measure distinct behavioral or physiological phenomena based on linear numerical gradient or yes/no alternatives. The Numeric Pain Scale (NRS) pain numerical score(0-10 score, 0: no pain, 10: worst imaginable pain). A pain measurement list about quiet NRS score and cough NRS score at different postoperative time will be used.	Score from the end of the operation and follow-up at the time point specified in the scoring form for a total of 27 hours.
Secondary	Dosage of remedial analgesics postoperatively	If the participant still feels severe pain after operation and needs additional analgesic drugs for treatment, we will record the type and dose of drugs used by the patient.	It takes about 24 hours.
Secondary	Hemodynamic fluctuation	Hemodynamic fluctuation during perioperative period. The levels of SBP in mmHg, DBP in mmHg, MAP in mmHg and HR in times/minute in basic(T0), after induction(T1), preoperative(T2) and after establishing pneumoperitoneum(T3) 1h after the pneumoperitoneum(T4) and Immediately after operation(T5), Before(T6) and after(T7) extubation were recorded.	From the beginning of the general anesthesia induction to the time leaving PACU, it takes about 4 hours.
Secondary	Ramsay scale	Ramsay scale is the most widely used sedation scoring standard in clinic, which is simple and practical. This scale has multiple advantages: it is reproducible, easily executed and has good applicability. This has made the scale the most widely used to assess level of sedation for procedures in pediatrics. It is divided into six levels(1-6): 1 shows patient is anxious and agitated or restless, or both; 2 shows patient is co-operative, oriented, and tranquil; 3 shows patient responds to commands only; 4 shows patient exhibits brisk response to light tactile stimuli or loudauditory stimulus; 5 shows patient exhibits sluggish response to light tactile stimuli or loud auditory stimulus; 6 shows patient exhibits no response.	Score from the end of the operation and follow-up at the time point specified in the scoring form for a total of 27 hours.
Secondary	recovery time	From the time when the patient entered PACU to the time when the participant meets the standard of leaving the PACU.	It will take up to 1 hour or 2 hours.
Secondary	The levels of C-reactive protein (CRP)	We will collect the participant's blood at the time before surgery(T0), after surgery(T1), and 24h after surgery(T2) to obtain the levels of C-reactive protein (mg/L).	It takes about 24 hours.
Secondary	The levels of cortisol (COR).	We will collect the participant's blood at the time before surgery(T0), after surgery(T1), and 24h after surgery(T2) to obtain the levels of cortisol (nmol/L).	It takes about 24 hours.
Secondary	The levels of blood glucose (BG)	We will collect the participant's blood at the time before surgery(T0), after surgery(T1), and 24h after surgery(T2) to obtain the levels of blood glucose (mmol/L).	It takes about 24 hours.
Secondary	The levels of interleukin-6 (IL-6).	We will collect the participant's blood at the time before surgery(T0), after surgery(T1), and 24h after surgery(T2) to obtain the levels of IL-6 (pg/mL).	It takes about 24 hours.
Secondary	Scores of 15-item Quality of Recovery (QoR-15) scale 24 hours postoperatively of participants.	The QoR-15 scale is a validated tool to assess the quality of postoperative recovery (QoR) from 0 to 150. The QoR was classified as excellent (QoR-15 > 135), good (122 = QoR-15 = 135), moderate (90 = QoR-15 = 121) or poor (QoR-15 < 90).	One day after the surgery.
Secondary	Rate of postoperative nausea and vomiting	Postoperative nausea and vomiting will be recorded if it happens.	It takes about 24 hours.
Secondary	Acceptability of participants with laryngeal mask 24 hours after surgery.	One day after surgery, we will record the acceptability of laryngeal mask and the degree of postoperative pharyngeal pain of the participants. Acceptability of participants with laryngeal mask will be assessed by whether the participant was willing to receive laryngeal mask anesthesia again. Pharyngeal pain can be evaluated using the Numeric Pain Scale (NRS) pain numerical score. A subjective psychometric response scale used to measure distinct behavioral or physiological phenomena based on linear numerical gradient or yes/no alternatives. The Numeric Pain Scale (NRS) pain numerical score(0-10 score, 0: no pain, 10: worst imaginable pain).	One day after the surgery.